tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

OPT

Opthea Limited Completes Nasdaq Delisting
Company AnnouncementsOpthea Limited Completes Nasdaq Delisting
1M ago
6K
OPT
Opthea Limited Announces Successful AGM Results
PremiumCompany Announcements
Opthea Limited Announces Successful AGM Results
2M ago
6K
OPT
Opthea Limited Schedules Virtual Annual General Meeting for November 2025
PremiumCompany Announcements
Opthea Limited Schedules Virtual Annual General Meeting for November 2025
3M ago
6K
OPT
Opthea Limited Reports Improved Financial Results Amid R&D Challenges
PremiumCompany Announcements
Opthea Limited Reports Improved Financial Results Amid R&D Challenges
4M ago
6K
OPT
Opthea terminates COAST trial, announces ShORe trial misses endpoint
PremiumThe Fly
Opthea terminates COAST trial, announces ShORe trial misses endpoint
9M ago
OPT
Opthea downgraded to Perform from Outperform at Oppenheimer
PremiumThe FlyOpthea downgraded to Perform from Outperform at Oppenheimer
9M ago
OPT
Opthea downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Opthea downgraded to Market Perform from Outperform at Leerink
9M ago
OPT
Opthea cut to Market Perform at Leerink on failed sozinibercept trial
Premium
The Fly
Opthea cut to Market Perform at Leerink on failed sozinibercept trial
9M ago
OPT
Opthea double downgraded to Underperform from Buy at Jefferies
PremiumThe Fly
Opthea double downgraded to Underperform from Buy at Jefferies
9M ago
OPT
Opthea downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Opthea downgraded to Neutral from Buy at H.C. Wainwright
9M ago
OPT
CoreWeave initiated, Carvana upgraded: Wall Street’s top analyst calls
PremiumThe Fly
CoreWeave initiated, Carvana upgraded: Wall Street’s top analyst calls
9M ago
AJG
AON
Hold Rating Issued for Opthea Limited Amid Uncertainty Following Phase 3 Trial Failure
PremiumRatings
Hold Rating Issued for Opthea Limited Amid Uncertainty Following Phase 3 Trial Failure
9M ago
OPT
Opthea Limited: Hold Rating Amid Phase 3 Trial Failure and Financial Uncertainty
PremiumRatingsOpthea Limited: Hold Rating Amid Phase 3 Trial Failure and Financial Uncertainty
9M ago
OPT
Opthea’s COAST Phase 3 Trial Fails to Meet Primary Endpoint, Raising Financial Concerns
Premium
Company Announcements
Opthea’s COAST Phase 3 Trial Fails to Meet Primary Endpoint, Raising Financial Concerns
9M ago
6K
OPT
Opthea COAST trial misses primary endpoint, enters talks with DFA Investors
Premium
The Fly
Opthea COAST trial misses primary endpoint, enters talks with DFA Investors
9M ago
OPT
Opthea Ltd (ADR) trading halted, news pending
PremiumThe Fly
Opthea Ltd (ADR) trading halted, news pending
10M ago
OPT
Opthea Limited: Promising Clinical Trials and Strong Financial Position Support Buy Rating with $13 Target
PremiumRatings
Opthea Limited: Promising Clinical Trials and Strong Financial Position Support Buy Rating with $13 Target
10M ago
OPT
Opthea announces Phase 2b Wet AMD publication
PremiumThe Fly
Opthea announces Phase 2b Wet AMD publication
10M ago
OPT
Opthea Limited Reports Increased Losses Amid Clinical Advancements
PremiumCompany Announcements
Opthea Limited Reports Increased Losses Amid Clinical Advancements
10M ago
OPT
Opthea reports 1H adjusted EPS ($5.73) vs. ($14.25) last year
PremiumThe FlyOpthea reports 1H adjusted EPS ($5.73) vs. ($14.25) last year
10M ago
OPT
Opthea announces anticipated milestones
Premium
The Fly
Opthea announces anticipated milestones
10M ago
OPT
Optimistic Buy Rating for Opthea Limited Driven by Promising Phase 3 Trials and Innovative AMD Treatment
Premium
Ratings
Optimistic Buy Rating for Opthea Limited Driven by Promising Phase 3 Trials and Innovative AMD Treatment
10M ago
OPT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >